PHASE IV AI
“Artificial intelligence (AI) enables data-driven innovations in health care. AI systems, which process vast amounts of data quickly and in detail, show promise both as a tool for preventive health care and clinical decision-making. However, the distributed storage and limited access to health data form a barrier to innovation, as developing trustworthy AI systems requires […]
BIOSTREAMS
During the last decades, overweight & obesity rates have reached epidemic proportions across EU. Prevalence in childhood is particularly alarming, resulting in psychological impacts & increased risks for NCDs. However, although obesity-related research has provided interesting results, several issues arise due to the lack of meta-reviews & the nature of data collected. To address this, […]
AI PROGNOSIS
Parkinson’s disease (PD) is the most common neurodegenerative movement disorder, with a multifactorial aetiology, heterogeneous manifestation of motor and non-motor symptoms, and no cure. PD is often missed or misdiagnosed, as early symptoms are subtle and common with other diseases, allowing for considerable damage to occur before treatment. Moreover, selecting the optimal medication regimen is […]
ONCOSCREEN
With Colorectal Cancer (CRC) being accountable for 12.4% of all deaths due to cancer, and with only 14% of EU citizens participating in screening programmes, there is an urgent need for accurate, non-invasive, cost-effective screening tests based on novel technologies and an increased awareness on the disease and its detection. Furthermore, personalized approaches for screening […]
DIOPTRA
DIOPTRA inspires to address the aforementioned issues by incorporating new technologies for Colorectal Cancer (CRC) risk assessment, screening and progression, while providing robust evidence-based indications of CUP relationships to CRC. We aim to build a strongevidence base toward a unified holistic protocol for primary CRC screening, applicable both to undiagnosed cancer patients (via scheduled screening […]
iPROLEPSIS
Psoriatic Arthritis (PsA) is a chronic, progressive, inflammatory disease affecting 1-2% of the general population, while manifesting in up to 30% of people with psoriasis (PsO). The transition from health to PsA is currently untraceable; diagnosis of early PsA is challenging even in PsO patients. Untimely diagnosis is common and contributes to early deterioration of […]
RELEVIUM
“Pancreatic cancer has the lowest survival rate amongst other cancers and is responsible for 95,000 deaths every year in the EU. Its treatment is usually palliative, aiming at slowing tumour progression and at symptom management. The main hypothesis of RELEVIUM is that quality of life (QoL) of advanced pancreatic cancer patients can be significantly improved […]
